Research & Evidence
ECS Restore separates established biology, mechanistic hypotheses and exploratory observations. Each layer carries a different evidentiary weight.
The framework is under investigation and requires independent validation through appropriate experimental and clinical approaches.
01
Established biology, mechanistic hypotheses and exploratory observations are separated.
02
Each scientific claim is evaluated according to the evidence required to support it.
03
Physiological inference requires prospective validation before clinical interpretation.
Established biology
Literature
The endocannabinoid system, membrane composition, GPCR regulation, sleep physiology and autonomic control are supported by extensive experimental and physiological literature.
Evidence standard
Supported by peer-reviewed experimental studies and established physiological principles.
Mechanistic hypothesis
Testable model
ECS Restore investigates whether cellular environment, lipid availability and physiological state influence CB1-associated adaptive regulation.
Evidence standard
Requires focused mechanistic studies testing specific causal relationships.
Exploratory platform
Requires validation
The platform explores whether longitudinal measurements combining sleep physiology, autonomic regulation and biological context can generate reproducible indicators of adaptive capacity.
Evidence standard
Requires independent validation, replication and comparison against appropriate reference methods.
Exploratory evidence synthesis
A source-transparent comparison of published sleep, autonomic and human frontal-cortex CB1 trajectories, normalized to age 30.
The CB1 line provides a human age-related context. It is not evidence that CB1 change causes the other trajectories.
Explore the complete trajectory atlasScientific anchors
CB1-knockout mice had reduced recovery NREM delta power and less stable NREM bouts after sleep deprivation.
Pava et al. 2014Acute CB1 agonism altered spindle-rich intermediate sleep in rats, increasing spindle amplitude and shifting peak frequency downward.
Kocsis et al. 2025CB1-knockout mice showed altered state-dependent HR control; metabolic challenge exposed lower baroreflex sensitivity.
Silvani et al. 2014These preclinical studies support biological relevance. They do not demonstrate that declining CB1 availability causes age-related change in human slow-wave sleep, spindle density or RMSSD.
Adaptive capacity
Most physiological measurements describe a current state. Resilience also depends on what happens when physiology is challenged: can the system sense a perturbation, respond, recover and remodel?
Human skeletal-muscle multi-omics · Janssens et al. 2026 [AC1]
Physiological reserve
In the study comparison, trained older adults lacked about half of the age-related molecular differences seen between young and normally active older adults, particularly in cellular-respiration and energy-metabolism biology.
Adaptive response
Among older adults, greater physical fitness was associated with a larger exercise-induced transcriptional immune/stress response following acute exercise.
The study used transcriptomics, lipidomics and metabolomics in human skeletal muscle before and after an acute submaximal exercise bout. It is independent precedent for separating baseline state from response to challenge—not validation of ECS Restore.
ECS Restore working framework
Adaptive phenotype = current state + response to challenge + recovery + longitudinal adaptation.
Adaptive gain is currently a research construct, not a validated clinical biomarker.
Age-, training- and fitness-associated skeletal-muscle molecular differences, including acute exercise responses.
Physiological reserve and responsiveness to perturbation may be complementary dimensions of adaptive capacity.
Whether sleep-state autonomic dynamics, metabolic flexibility, substrate oxidation, fatty-acid state or SAG prospectively quantify that latent capacity.
Scientific rationale and measurement framework
Biological adaptation emerges from coordinated regulation across multiple systems. Sleep provides a recurring physiological window in which behavioural demands are reduced and intrinsic neural and autonomic organisation can be studied together.
01 — Sleep architecture
Sleep EEG captures coordinated brain activity through slow-wave activity, spindle dynamics and stage stability. These patterns reflect how neural networks enter, maintain and transition between functional states.
CB1-related signalling influences neuronal excitability, synaptic regulation and sleep-related physiology in experimental systems.
02 — Autonomic regulation
The autonomic nervous system continuously adjusts physiological state. Sleep-staged HRV allows regulation to be studied within defined physiological states rather than reduced to a single overnight average.
CB1 participates in central and peripheral regulation of stress responses and autonomic physiology.
03 — Integrated phenotype
Adaptive capacity is unlikely to be represented by one physiological variable. The framework therefore tests whether coordinated sleep and autonomic patterns provide information beyond isolated measurements.
The hypothesis is not that sleep measures CB1 directly, but that downstream physiological organisation may contain information about adaptive regulatory state.
From rationale to measurement
ECS Restore combines sleep-associated brain activity, sleep-state regulation and autonomic physiology in a multivariate framework. The aim is to generate a quantitative hypothesis about physiological state that can be challenged in prospective studies.
Scientific boundary
The framework does not directly measure CB1 receptor density, occupancy or signalling. It tests whether coordinated physiological patterns may track an adaptive regulatory state in which CB1-related biology participates.
Overnight physiological signals
From observation to hypothesis
The sequence below describes the research logic, not a causal conclusion. Its purpose is to turn an exploratory observation into a pre-specified validation question.
Conceptual longitudinal sequence
Cannabinoid exposure
sustained reduction
CB1 Availability Index
inferred trajectory
Functional Sufficiency Score
convergent physiology
Exploratory longitudinal observation
An exploratory longitudinal observation integrating whole-blood fatty-acid composition, sleep-associated physiology and downstream measures related to adaptive capacity.
Exploratory founder observation. These trajectories are hypothesis generating and require independent validation.
These observations do not establish causality. Their purpose is to identify measurable relationships that can be translated into focused research questions.
Research streams
Connected research streams translate a broad systems hypothesis into experimentally tractable questions.
How do longitudinal lipid patterns relate to membrane-relevant biological context?
Do sleep-stage dynamics contain reproducible signals of adaptive regulation?
Can state-aware autonomic measures improve interpretation beyond single summary metrics?
How do physiological systems change when an intervention or environmental demand is introduced?
White papers
Foundational documents describing the biological hypotheses, measurement approaches and research frameworks guiding ECS Restore.
Scientific framework
A hypothesis-driven systems biology framework exploring how mitochondrial GPCRs may translate physiological state into adaptive mitochondrial regulation.
Read white paperMeasurement framework
A proof-of-concept biomarker framework investigating whether sleep EEG and autonomic physiology can provide a non-invasive window into longitudinal CB1 regulatory dynamics.
Read white paperBiological state framework
A substrate-driven framework exploring whether longitudinal fatty-acid composition can provide a measurable representation of cellular environment, membrane context and biological adaptation.
Read white paperState-response coupling across one night
Sleep provides repeated physiological perturbations. Autonomic physiology reorganises around those transitions; the construct asks about the magnitude, latency, coherence and reproducibility of that response.
03 · State-response coupling
A candidate phenotype of state-dependent autonomic responsiveness.
Candidate construct—not a validated biomarker, clinical score or direct measure of CB1 physiology.
COMPARABLE STATE TRANSITION · DIFFERENT RESPONSE
A smaller or less coordinated autonomic shift follows the same sleep-state change.
A larger, more coherent autonomic shift follows the same sleep-state change.
Exploratory observation
Personal data · descriptiveIn this example, RMSSD was 50–70 ms during a three-minute awake rest recording and 100–140 ms during N2 sleep.
Descriptive within-person ranges. Awake rest and N2 are different recording contexts; this observation motivated the state-response hypothesis but does not by itself estimate Sleep Autonomic Gain.
Scientific boundary
Exploratory physiological construct. Sleep Autonomic Gain describes state-dependent autonomic responsiveness during sleep. Whether this construct provides reproducible information about adaptive capacity or CB1-associated physiology requires prospective validation.
Curated reference architecture
Topic codes connect claims to source notes below. References support only the stated observation; they do not validate the broader ECS Restore framework, biomarker or formulation.
In a neuronal cell model, highly unsaturated fatty acids including AA, EPA and DHA changed membrane fluidity and membrane-dependent processing.
CB1 palmitoylation influenced cholesterol/caveolin interaction, membrane-domain partitioning and agonist-induced internalisation in cellular models.
In the paper's Fat-1 mouse comparison, endogenous omega-3 enrichment was associated with approximately 86% lower hepatic 2-AG and 50% lower hepatic AEA. These are model- and tissue-specific observations, not universal effects of omega-3 enrichment.
In a small double-blind randomised trial in 44 people with coronary artery disease, 10 weeks of flaxseed-oil supplementation changed erythrocyte fatty acids, reduced serum AEA, increased peripheral CB2 mRNA and produced a non-significant trend toward lower CB1 mRNA.
This primary lipidomics study describes conversion of membrane-stored EPA and DHA through N-acylethanolamine pathways to EPEA and DHEA and identifies downstream omega-3-derived endocannabinoid epoxides. EPEA and DHEA have pharmacology distinct from canonical 2-AG and AEA.
Targeted lipidomics in mice showed that short-term dietary DHA enrichment shifted selected brain and plasma N-acylethanolamine and glycerol-ester metabolites toward EPA- and DHA-derived species, including increased EPG and DHEA. DHG did not significantly increase in that experiment, underscoring that substrate effects are metabolite- and compartment-specific.
Across 13,867 US whole-blood dried blood spot samples, mean EPA+DHA was 2.7% (SD 1.5), the median AA:EPA ratio was 22.3 (IQR 20.5), and the median total omega-6:omega-3 ratio was 9.0 (IQR 4.5). DBS measures correlate with RBC long-chain omega-3 status, but the study did not report a US mean RBC AA percentage. Samples were crowd-sourced and included supplement users and non-users.
Nationally representative NHANES 2021–2023 erythrocyte membrane measurements found AA at approximately 17% of measured fatty acids, second in prevalence after stearic acid. The study's primary focus was the US omega-3 index and reported that more than half of the population had an index below 4%.
In mice, increasing dietary linoleic acid from 1% to 8% of energy increased arachidonic acid in phospholipids and elevated the arachidonic-acid-derived endocannabinoids 2-AG and AEA in liver. The effect was peripheral and tissue-specific; cortical endocannabinoids did not change.
Pharmacological manipulation in mice supported a role for endocannabinoid signalling through CB1 in NREM stability and low-frequency EEG regulation.
A primary cellular study linking CB1 membrane interactions to localisation and internalisation biology.
Lifelong dietary omega-3 insufficiency in mice abolished endocannabinoid-mediated synaptic depression in selected brain regions and reduced CB1 coupling efficiency to Gi/o proteins. The study did not directly measure increased β-arrestin recruitment or internalisation.
Experimental receptor studies established roles for GRK3 and β-arrestin 2 in CB1 desensitisation and showed that desensitisation and internalisation can involve distinct receptor determinants.
Insulin increased CB1 protein, but not CB1 mRNA, in AML12 cells, primary rat hepatocytes and rat liver. Mechanistic experiments implicated ERK signalling and suppression of lysosomal CB1 degradation. Translation to human hepatic or neural CB1 regulation remains unestablished.
CDC estimates for 2023 indicate that 40.1 million people in the United States—12.0% of the population—had diagnosed or undiagnosed diabetes, while 115.2 million adults had prediabetes. CDC reports that approximately 90–95% of diagnosed adult diabetes is type 2.
A CB1 agonist changed spindle architecture and reorganised intermediate-sleep/REM episodes in rats.
Preclinical evidence that CB1-related manipulations alter NREM bout stability and EEG power; this is not a validated human biomarker.
A small human pilot trial found acute THC/CBD-related changes in REM timing and regional sleep EEG; exposure was not a selective CB1 probe.
Vaporised cannabis altered cortical spectral power and spindle coherence in rats; the study did not isolate endogenous CB1 function.
Human slow-oscillation–spindle coupling correlated with overnight memory consolidation, supporting its physiological relevance but not CB1 specificity.
The CB1 antagonist SR141716A changed slow-wave and REM sleep and low-frequency EEG power in rats.
CB1 antagonism increased sleep fragmentation in mice; enhanced endocannabinoid tone increased bout length in some groups.
CB1 antagonism changed vigilance-state bout and transition dynamics in rats.
CB1 deletion altered sleep-state cardiorespiratory control in mice under spontaneous and metabolic-challenge conditions.
Preclinical evidence that CB1-sensitive cannabinoid effects can alter sympathetic cardiovascular regulation.
Primary binding and activation work showing that fatty acids, including EPA, can act as PPAR ligands in experimental systems.
Dietary EPA/DHA substantially replaced AA in membrane phospholipids across several rat tissues and changed downstream lipid-metabolite profiles.
Six weeks of endurance training in healthy men increased skeletal-muscle PGC-1 and PPARα expression, changes proposed to contribute to mitochondrial and oxidative adaptation.
Human skeletal-muscle biopsies showed a marked transient increase in PGC-1α transcription after endurance exercise, supporting its role in the mitochondrial adaptation programme.
In healthy men, a single moderate-intensity exercise session increased circulating anandamide in association with memory-related outcomes; this does not establish chronic CB1 remodelling.
Human skeletal-muscle transcriptomics, lipidomics and metabolomics before and after acute submaximal exercise. In the study comparison, 50% of age-related molecular differences were absent in trained older adults; among older adults, fitness was positively correlated with the magnitude of exercise-induced transcriptional immune/stress responses.
Translational innovation
Understanding adaptive physiology requires more than identifying biological mechanisms. Translation requires approaches that connect molecular context, physiological state and measurable outcomes.
01
Investigating how cellular environment, substrate availability and physiological context influence adaptive signalling.
02
Developing approaches that combine longitudinal sleep physiology and autonomic regulation to explore measurable indicators of biological state.
03
Exploring non-cannabinoid approaches designed to support endogenous regulatory processes while avoiding direct receptor agonism.
Intellectual property
ECS Restore has filed intellectual property relating to approaches for supporting endogenous adaptive signalling and translating biological state into measurable physiological frameworks.
The protected concepts form part of a broader scientific platform exploring how biological context influences receptor-mediated adaptation, physiological resilience and adaptive capacity.
Scientific boundary
The intellectual property and associated frameworks are under development and require independent scientific validation. ECS Restore distinguishes between established biology, mechanistic hypotheses and exploratory translational concepts.
